American Portfolios Advisors’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $809K | Sell |
14,450
-682
| -5% | -$38.2K | 0.03% | 487 |
|
|
2022
Q2 | $783K | Sell |
15,132
-419
| -3% | -$21.7K | 0.03% | 503 |
|
|
2022
Q1 | $1.13M | Sell |
15,551
-1,820
| -10% | -$132K | 0.04% | 446 |
|
|
2021
Q4 | $2.05M | Buy |
17,371
+915
| +6% | +$108K | 0.07% | 275 |
|
|
2021
Q3 | $2.21M | Sell |
16,456
-1,738
| -10% | -$233K | 0.08% | 249 |
|
|
2021
Q2 | $2.95M | Sell |
18,194
-10,019
| -36% | -$1.62M | 0.11% | 181 |
|
|
2021
Q1 | $2.26M | Buy |
28,213
+4,910
| +21% | +$394K | 0.1% | 201 |
|
|
2020
Q4 | $1.27M | Buy |
23,303
+9,369
| +67% | +$510K | 0.06% | 285 |
|
|
2020
Q3 | $277K | Buy |
13,934
+7,806
| +127% | +$155K | 0.02% | 684 |
|
|
2020
Q2 | $129K | Buy |
6,128
+4,728
| +338% | +$99.4K | 0.01% | 911 |
|
|
2020
Q1 | $17.1K | Buy |
1,400
+1,041
| +290% | +$12.7K | ﹤0.01% | 1588 |
|
|
2019
Q4 | $5.27K | Hold |
359
| – | – | ﹤0.01% | 2256 |
|
|
2019
Q3 | $4.79K | Sell |
359
-100
| -22% | -$1.34K | ﹤0.01% | 2213 |
|
|
2019
Q2 | $7.51K | Hold |
459
| – | – | ﹤0.01% | 2017 |
|
|
2019
Q1 | $7.84K | Hold |
459
| – | – | ﹤0.01% | 1919 |
|
|
2018
Q4 | $6.27K | Sell |
459
-130
| -22% | -$1.77K | ﹤0.01% | 1791 |
|
|
2018
Q3 | $16.9K | Hold |
589
| – | – | ﹤0.01% | 1552 |
|
|
2018
Q2 | $16.1K | Buy |
589
+464
| +371% | +$12.7K | ﹤0.01% | 1534 |
|
|
2018
Q1 | $2.64K | Buy |
+125
| New | +$2.64K | ﹤0.01% | 2041 |
|